MarkNtel Advisors recently published a detailed industry analysis of the Global Cancer Gene Panel and Profiling. The report covers growth trends, geographical marketing strategies, challenges, opportunities, and drivers influencing the market.

Global Cancer Gene Panel and Profiling Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2030

The Cancer Gene Panel and Profiling Market is estimated to grow at a CAGR of around 15.5% during the forecast period, i.e., 2024-29.

What are the major Driver the Global Cancer Gene Panel and Profiling industry?

Growing Prevalence of Hereditary Cancer Cases Globally – The escalating prevalence of hereditary cancer occurrences on a global scale has amplified the demand for genetic panels & profiling testing within the market. This has been mainly because the cancer gene panel and profiling services are highly effective & accurate in the detection of hereditary cancer cases.

Also, genetic testing companies have started offering a comprehensive array of services, including advanced screening & diagnostics in recent years. As a result, there has been an increasing adoption of these testing services by research institutions & clinical laboratories engaged in detecting biomarkers of hereditary cancer cases. This robust adoption trajectory is a direct response to the persistent surge in hereditary cancer cases, as evidenced by historical trends. For instance:

• In 2022, the National Cancer Institute indicated that approximately 10% of all cancer cases witnessed were attributable to hereditary genetic mutations.

As the mutations in hereditary cancer are only pinpointed to specific genes responsible for shielding the body against cancer, it led to genetic testing services coming up as a pivotal method of diagnosis. Notably, clinicians have embraced this technique with significant impact, thereby fostering substantial growth within the Cancer Gene Panel and Profiling Market.

Access the detailed PDF Sample report –

https://www.marknteladvisors.com/query/request-sample/cancer-gene-panel-profiling-market.html

✅In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.

What segments define the Global Cancer Gene Panel and Profiling from 2024 to 2029? How do these segments contribute to market dynamics and growth?

• By Technology
• Next-generation Sequencing (NGS)- Market Size & Forecast 2019-2029, USD Million
• Polymerase Chain Reaction(PCR)- Market Size & Forecast 2019-2029, USD Million
• Microarray- Market Size & Forecast 2019-2029, USD Million
• Mass Spectrometry- Market Size & Forecast 2019-2029, USD Million
• Others (Fluorescence in-situ hybridization, Immunohistochemistry, etc.)- Market Size & Forecast 2019-2029, USD Million
• By Application
• Oncology Research- Market Size & Forecast 2019-2029, USD Million
• Personalized Medicine- Market Size & Forecast 2019-2029, USD Million
• Drug Development- Market Size & Forecast 2019-2029, USD Million
• Clinical Diagnostics- Market Size & Forecast 2019-2029, USD Million
• By Cancer Type
• Breast Cancer- Market Size & Forecast 2019-2029, USD Million
• Lung Cancer- Market Size & Forecast 2019-2029, USD Million
• Prostrate Cancer- Market Size & Forecast 2019-2029, USD Million
• Colorectal Cancer- Market Size & Forecast 2019-2029, USD Million
• Others (Ovarian Cancer, Leukemia, etc.) - Market Size & Forecast 2019-2029, USD Million

According to report, The heightened presence of Lung Cancer patients globally has widely accumulated the demand for more effective diagnostic options over the past few years. According to the International Agency for Research on Cancer (IARC), lung cancer remains the leading cause of cancer deaths, with an estimated 1.8 million deaths (18%) in 2020.

• By Cell Type
• Germline - Market Size & Forecast 2019-2029, USD Million
• Somatic - Market Size & Forecast 2019-2029, USD Million
• By End-User
• Hospital & Clinics- Market Size & Forecast 2019-2029, USD Million
• Research Institutes- Market Size & Forecast 2019-2029, USD Million
• Diagnostic Laboratories- Market Size & Forecast 2019-2029, USD Million
• Pharmaceutical and Biotechnology- Market Size & Forecast 2019-2029, USD Million

According to report, Research Institutes are poised to capture the potential share of the Global Cancer Gene Panel and Profiling Market in the coming years.

Explore the Complete Global Cancer Gene Panel and Profiling Analysis Report –

https://www.marknteladvisors.com/research-library/cancer-gene-panel-profiling-market.html

Geographical Analysis: Global Cancer Gene Panel and Profiling

• By Region
• North America
• South America
• Europe
• The Middle East & Africa
• Asia-Pacific

Global Cancer Gene Panel and Profiling Share & Competitive Landscape:

The Cancer Gene Panel and Profiling Market is characterized by intense competition, with several key players driving growth through innovation, market expansion, and strategic investments. The competitive landscape provides valuable insights into the industry's leading companies, highlighting their strengths, financial performance, and market influence.

Leading Companies in the Global Cancer Gene Panel and Profiling are:

• 10x Genomics, Inc.
• Neo genomics
• Flugent Genetics
• Centogene N.V.
• Geneseeq Technology Inc.
• Variantyx
• Genetron Holdings Limited
• Laboratory Corporation of America® Holdings (LabCorp)
• T. G Molecular
• Bio array Diagnostic genetic
• Biorad laboratories Inc.
• Enzo Lifesciences
• Eurofins Scientific
• Nanostring Technologies

Global Cancer Gene Panel and Profiling Industry Recent Developments

• 2023: Neo Genomics and Massive Bio announced a collaboration to leverage their expertise in biomarker testing, data analysis, machine learning, and biomarker and genomic profiling to accomplish a significant milestone within the field of oncology.

• 2022: Variantyx invested USD 41.5 million for its advanced genomic testing platform, with plans to target growth in precision oncology.

 Questions Addressed in this Study

1.What factors are driving the Global Cancer Gene Panel and Profiling growth?

2.How is the Global Cancer Gene Panel and Profiling expected to grow over the next five years?

3.What are the key insights into the current trends in the Global Cancer Gene Panel and Profiling?

4.What is the current size of the Global Cancer Gene Panel and Profiling, and how is it projected to change in the future?

6.What is the future outlook for the Global Cancer Gene Panel and Profiling in terms of technological advancements and market expansion?

For a Customized Analysis Report, Just Drop Your Inquiry Here –

https://www.marknteladvisors.com/query/request-customization/cancer-gene-panel-profiling-market.html

Why MarkNtel Advisors?

MarkNtel Advisors is a leading research, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.

More Research Studies Report:

-Biocomposites Market size was valued at around USD 36.9 billion in 2024 and is projected to reach USD 89 billion by 2030 with a CAGR of around 16%.

-Green Solvents Market size was valued at around USD 1.34 billion in 2024 & is projected to reach USD 1.87 billion by 2030 with a CAGR of around 5.7%.

For Media Inquiries, Please Contact:

Email: [email protected]

Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511

Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India

& emerging geographies allows our clients to formulate their strategies in a much more